Announcements Trials

Browse Landscape

Phase

Status

Completed 7 Terminated 4 Unknown 1 Suspended 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Depressive Disorder, Major 1 Breast Neoplasms 1

Interventions

Specimen Handling 33 Magnetic Resonance Spectroscopy 21 Biopsy 19 Cyclophosphamide 15 Nivolumab 10 Paclitaxel 9 Vincristine 8 Cisplatin 8 Bevacizumab 8 venetoclax 7 Prednisone 7 Gemcitabine 7 Doxorubicin 7 Azacitidine 7 pembrolizumab 6 Radiotherapy 6 Radiosurgery 6 Fluorouracil 6 Etoposide 6 Drug Therapy 6 Docetaxel 6 Surgical Procedures, Operative 5 Rituximab 5 Oxaliplatin 5 Irinotecan 5 Injections 5 Everolimus 5 Capecitabine 5 fludarabine phosphate 4 Taxes 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Escitalopram × Clear all

NCT04973930 2025-05-13

IPT

New York State Psychiatric Institute

Phase 3 Suspended

Breast Neoplasms, Depressive Disorder, Major

Data powered by HemOnc (CC BY 4.0) Colophon ⚡